This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,659 Years Active: 2014
Title: Cyril Jean Camille Titeux: Innovator in Antiviral Therapies
Introduction
Cyril Jean Camille Titeux is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of antiviral therapies, particularly in the treatment of Hepatitis C infections. Her innovative work has led to the development of a therapeutic regimen that combines PEG-interferon, ribavirin, and VX-950.
Latest Patents
Cyril holds a patent for a therapeutic regimen comprising PEG-interferon, ribavirin, and VX-950 for the treatment of hepatitis. This invention relates to antiviral therapies and compositions aimed at treating or preventing Hepatitis C infections in patients. It also encompasses various methods, kits, and pharmaceutical packs that include these compositions and dosage forms.
Career Highlights
Throughout her career, Cyril has focused on advancing antiviral treatments. Her dedication to research and innovation has positioned her as a key figure in the medical community. She continues to explore new avenues for improving patient outcomes in the realm of infectious diseases.
Collaborations
Cyril has collaborated with esteemed colleagues, including Robert S Kauffman and Ramon Polo. These partnerships have enhanced her research efforts and contributed to the development of effective antiviral therapies.
Conclusion
Cyril Jean Camille Titeux is a pioneering inventor whose work in antiviral therapies has the potential to significantly impact the treatment of Hepatitis C. Her innovative approaches and collaborations highlight her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile